Cargando…
Impact of Remdesivir on the Treatment of COVID-19 During the First Wave in Spain
INTRODUCTION: Spain was one of the most affected countries during the first wave of COVID-19, having the highest mortality rate in Europe. The aim of this retrospective study is to estimate the impact that remdesivir—the first drug for COVID-19 approved in the EU—would have had in the first wave. ME...
Autores principales: | Soriano, Alejandro, Montejano, Rocío, Sanz-Moreno, José, Figueira, Juan Carlos, Grau, Santiago, Güerri-Fernández, Robert, Castro-Gómez, Antonio, Pérez-Román, Inés, Hidalgo-Vega, Álvaro, González-Domínguez, Almudena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196270/ https://www.ncbi.nlm.nih.gov/pubmed/34118007 http://dx.doi.org/10.1007/s12325-021-01804-9 |
Ejemplares similares
-
Economic valuation of informal care in cerebrovascular accident survivors in Spain
por: Oliva-Moreno, Juan, et al.
Publicado: (2013) -
Successful management of remdesivir extravasation
por: Conde-Estévez, David, et al.
Publicado: (2022) -
The economic burden of pulmonary arterial hypertension in Spain
por: Zozaya, Néboa, et al.
Publicado: (2022) -
Third wave of COVID-19 in Madrid, Spain
por: Soriano, Vicente, et al.
Publicado: (2021) -
The economic burden of disease of epithelial ovarian cancer in Spain: the OvarCost study
por: Delgado-Ortega, Laura, et al.
Publicado: (2018)